Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lynn Tanoue

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Chest|August 14, 2021
Racial Differences in Adherence to Lung Cancer Screening Follow-up: A Systematic Review and Meta-analysisYukiko Kunitomo, Brett Bade, Craig G Gunderson, et al.
Lung Cancer (Amsterdam, Netherlands)|April 19, 2024
Trends and predictors of Quality of Life in lung cancer survivorsBrett C Bade, Julian Zhao, Fangyong Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2009
High expression of mammalian target of rapamycin is associated with better outcome for patients with early stage lung adenocarcinomaValsamo K Anagnostou, Gerold Bepler, Konstantinos N Syrigos, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 27, 2010
Should the 7th edition of the lung cancer stage classification system change treatment algorithms in non-small cell lung cancer?Daniel J Boffa, Frank C Detterbeck, Erica J Smith, et al.
Journal of Computer Assisted Tomography|October 13, 2023
Impact of the COVID-19 Pandemic on Lung Cancer Screening Processes in a Northeast Tertiary Health Care NetworkBrooks V Udelsman, Frank Detterbeck, Lynn Tanoue, et al.
Chest|November 29, 2012
Use of new treatment modalities for non-small cell lung cancer care in the Medicare populationMichael T Vest, Jeph Herrin, Pamela R Soulos, et al.
Chest|May 19, 2026
Natural history, treatment, survival, and causes of mortality in patients with subsolid and ground-glass nodulesJustin M Bader, Samantha R Prince, William de Santis, et al.
American Journal of Respiratory and Critical Care Medicine|May 5, 2026
NRT Starter Packs and Gain-Framed Messages to Promote Smoking Cessation in Lung Cancer Screening: A Randomized TrialLisa M Fucito, Alana M Rojewski, Lynn Tanoue, et al.
Physics in Medicine and Biology|August 11, 2018
Improved discrimination between benign and malignant LDCT screening-detected lung nodules with dynamic over static <sup>18</sup>F-FDG PET as a function of injected doseQing Ye, Jing Wu, Yihuan Lu, et al.
Infection Control and Hospital Epidemiology|May 4, 2006
High rate of negative results of tuberculin and QuantiFERON tests among individuals with a history of positive skin test resultsLloyd N Friedman, Esther R Nash, June Bryant, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Chest|August 14, 2021
Racial Differences in Adherence to Lung Cancer Screening Follow-up: A Systematic Review and Meta-analysisYukiko Kunitomo, Brett Bade, Craig G Gunderson, et al.
Lung Cancer (Amsterdam, Netherlands)|April 19, 2024
Trends and predictors of Quality of Life in lung cancer survivorsBrett C Bade, Julian Zhao, Fangyong Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2009
High expression of mammalian target of rapamycin is associated with better outcome for patients with early stage lung adenocarcinomaValsamo K Anagnostou, Gerold Bepler, Konstantinos N Syrigos, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 27, 2010
Should the 7th edition of the lung cancer stage classification system change treatment algorithms in non-small cell lung cancer?Daniel J Boffa, Frank C Detterbeck, Erica J Smith, et al.
Journal of Computer Assisted Tomography|October 13, 2023
Impact of the COVID-19 Pandemic on Lung Cancer Screening Processes in a Northeast Tertiary Health Care NetworkBrooks V Udelsman, Frank Detterbeck, Lynn Tanoue, et al.
Chest|November 29, 2012
Use of new treatment modalities for non-small cell lung cancer care in the Medicare populationMichael T Vest, Jeph Herrin, Pamela R Soulos, et al.
Chest|May 19, 2026
Natural history, treatment, survival, and causes of mortality in patients with subsolid and ground-glass nodulesJustin M Bader, Samantha R Prince, William de Santis, et al.
American Journal of Respiratory and Critical Care Medicine|May 5, 2026
NRT Starter Packs and Gain-Framed Messages to Promote Smoking Cessation in Lung Cancer Screening: A Randomized TrialLisa M Fucito, Alana M Rojewski, Lynn Tanoue, et al.
Physics in Medicine and Biology|August 11, 2018
Improved discrimination between benign and malignant LDCT screening-detected lung nodules with dynamic over static <sup>18</sup>F-FDG PET as a function of injected doseQing Ye, Jing Wu, Yihuan Lu, et al.
Infection Control and Hospital Epidemiology|May 4, 2006
High rate of negative results of tuberculin and QuantiFERON tests among individuals with a history of positive skin test resultsLloyd N Friedman, Esther R Nash, June Bryant, et al.
Pageof 3